Wolverine Trading, LLC Sarepta Therapeutics, Inc. Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 18,396 shares of SRPT stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,396

Previous 15,000 22.64%

Holding current value

$2.1 Million

Previous $2.37 Million 3.08%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $422,224 - $532,323	3,396 Added 22.64%	18,396 $2.3 Million
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $357,102 - $516,291	-3,151 Reduced 17.36%	15,000 $2.37 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $864,382 - $1.31 Million	9,225 Added 103.35%	18,151 $2.35 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $430,043 - $797,091	-6,389 Reduced 41.72%	8,926 $860,000
Q3 2023 Nov 15, 2023	BUY	$102.5 - $123.59 $618,382 - $745,618	6,033 Added 65.0%	15,315 $1.86 Million
Q2 2023 Aug 23, 2023	SELL	$106.4 - $157.19 $2.44 Million - $3.6 Million	-22,916 Reduced 71.17%	9,282 $1.06 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $2.57 Million - $3.41 Million	21,881 Added 212.09%	32,198 $4.38 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $281,601 - $368,906	2,792 Added 37.1%	10,317 $1.34 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $569,717 - $897,281	7,525 New	7,525 $825,000
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $598,997 - $770,604	-7,751 Reduced 29.39%	18,621 $1.69 Million
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $622,031 - $871,993	9,429 Added 55.65%	26,372 $2.34 Million
Q2 2021 Aug 06, 2021	SELL	$69.38 - $86.75 $1.5 Million - $1.88 Million	-21,666 Reduced 56.12%	16,943 $1.34 Million
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $913,312 - $2.14 Million	12,641 Added 48.68%	38,609 $2.82 Million
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $4,143 - $5,898	-33 Reduced 0.13%	25,968 $4.46 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $287,184 - $530,209	3,088 Added 13.48%	26,001 $4.23 Million
Q1 2020 May 11, 2020	SELL	$82.38 - $131.64 $2.78 Million - $4.45 Million	-33,780 Reduced 59.58%	22,913 $2.26 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $218,775 - $334,412	2,248 Added 4.13%	56,693 $6.12 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $5.95 Million - $8.34 Million	51,640 Added 1841.0%	54,445 $8.79 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $2.24 Million - $3.41 Million	-41,411 Reduced 93.66%	2,805 $208,000
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $1.47 Million - $1.75 Million	-30,902 Reduced 41.14%	44,216 $2.46 Million
Q3 2017 Nov 15, 2017	BUY	$35.73 - $47.15 $2.68 Million - $3.54 Million	75,118	75,118 $3.41 Million

Others Institutions Holding SRPT

# of Institutions

531

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Sarepta Therapeutics, Inc. Transaction History